Thenar oxygen saturation (StO₂) alterations during a spontaneous breathing trial predict extubation failure

Abstract

Background

Weaning from mechanical ventilation (MV) is a cardiovascular stress test. Monitoring the regional oxygenation status has shown promising results in predicting the tolerance to spontaneously breathe in the process of weaning from MV. Our aim was to determine whether changes in skeletal muscle oxygen saturation (StO₂) measured by near-infrared spectroscopy (NIRS) on the thenar eminence during a vascular occlusion test (VOT) can be used to predict extubation failure from mechanical ventilation.

Methods

We prospectively studied 206 adult patients with acute respiratory failure receiving MV for at least 48 h from a 30-bed mixed ICU, who were deemed ready to wean by their physicians. Patients underwent a 30-min spontaneous breathing trial (SBT), and were extubated according to the local protocol. Continuous StO₂ was measured non-invasively on the thenar eminence. A VOT was performed prior to and at 30 min of the SBT (SBT₃₀). The rate of StO₂ deoxygenation (DeO₂), StO₂ reoxygenation (ReO₂) rate and StO₂ hyperemic response to ischemia (H_AUC) were calculated.

Results

Thirty-six of the 206 patients (17%) failed their SBT. The remainder 170 patients (83%) were extubated. Twenty-three of these patients (13.5%) needed reinstitution of MV within 24 h. Reintubated patients displayed a lower H_AUC at baseline, and higher relative changes in their StO₂ deoxygenation rate between baseline and SBT₃₀ (DeO₂ Ratio). A logistic regression-derived StO₂ score, combining baseline StO₂, H_AUC and DeO₂ ratio, showed an AUC of 0.84 (95% CI 0.74–0.91) for prediction of extubation failure.

Conclusions

Extubation failure was associated to baseline and dynamic StO₂ alterations during the SBT. Monitoring StO₂-derived parameters might be useful in predicting extubation outcome.

Background

Weaning from ventilatory support is a challenge for critical care clinicians. Even in those patients who succeed a spontaneous breathing trial (SBT), failure of planned extubation occurs in up to 20% [1–5]. Importantly, failed extubation is associated with increased hospital mortality, prolonged ICU and hospital stays, and increased need for tracheostomy [6, 7]. Despite many respiratory and hemodynamic variables for predicting weaning success have been evaluated, few parameters have substantial predictive power [7, 8], and new predictive tools are needed.

The SBT is a cardiovascular stress test, and failure to wean from mechanical ventilation (MV) often reflects cardiovascular insufficiency to cope with the increased oxygen cost of breathing [9, 10]. Since the augmented oxygen cost of breathing is met by increases in respiratory muscle blood flow, diversion of flow away from “non-vital” tissues might occur, potentially causing hypoperfusion in areas such as the splanchnic and the peripheral circulation [11–15]. In fact, alterations in splanchnic and peripheral circulation, assessed by different technologies, have been associated with failure to tolerate an SBT [12–16]. In a preliminary study, our group demonstrated that changes in skeletal muscle oxygenation (StO₂) measured non-invasively on the thenar eminence by near-infrared spectroscopy (NIRS) were associated with the outcome of a 30-min SBT [16].

In the present study, we hypothesized that regional oxygenation alterations within the SBT would be associated with extubation failure after a clinically successful SBT.

Methods

Setting

This prospective observational study was conducted in a 30-bed medical-surgical intensive care unit at a university hospital. The local Ethics Committee (CEIC 2008/554) approved the study. Informed consent was obtained from the patient or their next of kin prior to the study initiation. This study is presented according to the STROBE recommendations for reporting observational studies [17].

Patients and data collection

We included adult patients (≥ 18-year old) receiving invasive mechanical ventilatory support for > 48 h and considered ready to wean by their physicians, according to the local protocol, and who never experienced any previous attempt of separation from MV. Eligibility to perform a weaning trial included partial or complete recovery from the underlying cause of acute respiratory failure; adequate gas exchange, as indicated by a partial pressure of arterial oxygen (PaO₂) > 60 mmHg to a fraction of inspired oxygen (FiO₂) < 0.4, with a positive end-expiratory pressure (PEEP) < 5 cmH₂O; adequate cough, with absence of excessive tracheobronchial secretion; core temperature < 38 °C; hemoglobin > 8 g/dL; stable cardiovascular status (heart rate < 120 beats min⁻¹, systolic blood pressure 90–160 mmHg), with no need for vasoactive agents; adequate level of consciousness (awake, alert and aware of their surroundings), with no further need for sedative agents. Patients were also tested for adequate pulmonary function, defined as a rapid shallow breathing index < 100 breaths min⁻¹ L⁻¹, and a maximal inspiratory pressure (MIP) < − 20 cmH₂O. Patients meeting these criteria were considered ready to wean, and were eligible for a subsequent spontaneous breathing trial.

Exclusion criteria included trauma in both upper limbs, and hematoma or skin lesions at the thenar eminence that could hinder placement of NIRS sensor probe. Patients with altered level of consciousness that could lead to central hypoventilation and/or impaired secretions’ management were excluded. Patients in whom their medical team decided to indicate preventive non-invasive ventilation following extubation were also excluded.

Study protocol

After inclusion, patients underwent a spontaneous breathing trial (SBT) for 30 min, defined as assisted spontaneous breathing with continuous positive airway pressure (CPAP) of 5 cm H₂O, or a T-tube trial, as prescribed by their medical team. Patients were in a semi-recumbent position, and FiO₂ was kept constant during the trial.

The evaluation criteria for SBT failure was defined as the presence of one or more of the following criteria during the trial: respiratory rate (RR) > 35 breaths/min for 5 min or longer; arterial pulse oximetry saturation (SpO₂) < 90%, heart rate (HR) > 140 beats/min or sustained increase or decrease in HR > 20%; systolic blood pressure > 180 mmHg or < 90 mmHg; increased anxiety and diaphoresis. Decision to remove the endotracheal tube was made independently of the study investigators by the attending physicians, who did not have access to the StO₂ data. Weaning success was defined as patient remaining free of MV for > 24 h after passing the SBT. Extubation failure was defined as the need for reinstitution of MV, either invasive or non-invasive, within 24 h following extubation.

Clinical parameters and outcomes

We collected demographic data: age, sex, diagnosis, and days on mechanical ventilation. Hemodynamic, respiratory and oxygenation variables were monitored continuously and recorded just before starting and at 30 min into the SBT. HR and mean arterial pressure (MAP) were recorded by routine bedside monitoring (Monitor Intellivue MP 70; Phillips Medizinsystems, Boeblingen, Germany). RR, tidal volume (Vt), minute ventilation (V_E), FiO₂ and SpO₂ were recorded at start and 30 min into the SBT. Arterial and/or central venous blood gas analyses were made when an arterial line and/or a central venous line was in place, respectively (ABL 700 series; Radiometer Medical, Copenhagen, Denmark).

The primary outcome of interest was extubation failure.

NIRS measurements

Tissue oxygen saturation (StO₂) was recorded continuously using the InSpectra 650 Tissue Spectrometer (Hutchinson Tech., Hutchinson, Minnessotta). This technology uses a wide gap 40-nm second derivative spectroscopic method, with measurements at four different wavelengths (680, 720, 760 and 800 nm), and has been previously validated for estimating local hemoglobin oxygen saturation in tissues [18]. The StO₂ 15-mm optical surface probe was placed on intact skin on the thenar eminence never placed adjacent to the site of radial artery cannulation. The InSpectra tissue spectrometer also measures relative hemoglobin concentration, presented as the tissue hemoglobin index (THI).

Vascular Occlusion Test (VOT) The VOT was performed as previously described [19, 20]. A blood pressure cuff (Portable Tourniquet System; Delfi Medical, Vancouver) was placed on the forearm, rapidly inflated 40 mmHg above systolic pressure, and kept inflated until StO₂ decreased to 40%. Then, the cuff was rapidly deflated. The resulting deoxygenation (DeO₂) and reoxygenation (ReO₂) slopes are reported as change in saturation over time (Fig. 1). Hyperemic response following the reoxygenation is reported as an area under the curve (H_AUC). We performed a VOT at the beginning of the SBT and again at 30 min into the SBT. NIRS-derived thenar muscle oxygen consumption (nirVO₂) was calculated as described by Skarda [21]: nirVO₂ = (DeO₂ slope)⁻¹/[(THI_start + THI_end)/2]. Relative changes in StO₂-derived parameters were calculated as the quotient between values at minute 30 and baseline (DeO₂ ratio, nirVO₂ ratio and ReO₂ ratio). Absolute StO₂- and VOT-derived variables were obtained using the InSpectra Research Software^® v4.01 (Hutchinson Technology). Two researchers (JM and JM) separately analyzed all the registers, and a database was constructed. When discrepancies were observed, the two researchers performed a third joint analysis.

Fig. 1.

StO₂ response to the Vascular Occlusion Test (VOT). The response to transient ischemia generates three main parameters in the continuous StO₂ recording: the StO₂ deoxygenation rate (DeO₂), the StO₂ reoxygenation rate (ReO₂), and the hyperemic response to ischemia, which is computed as the area under the curve of the hyperemic response (H_AUC) as referred to steady-state StO₂

Sample size calculation

Accepting an alpha risk of 0.05 and a beta risk of 0.20 in a two-sided test, estimating an SBT failure rate of 20%, and an extubation failure rate of 15%, we calculated that 200 patients were necessary to detect a positive likelihood ratio (LR +) of the test equal to or greater than 5.

Statistical analysis

Statistical analysis was performed by means of IBM SPSS statistics 20.0 software (IBM Corporation). Normal distribution of the studied variables was confirmed using the Kolmogorov–Smirnov test. Accordingly, continuous variables were expressed as mean ± standard deviation (SD), and categorical variables were expressed as absolute number and proportions (%). Chi square and Student’s t test were used to compare extubation success and failure groups. Student’s t test for paired measurements was used to analyze changes over time. Bivariate logistic regression analysis was used to obtain independent predictors of extubation success, and logistic regression models were used to create a predictive StO₂-score. Statistical significance was defined as p < 0.05 (two-tailed test).

Results

Two hundred-and-six patients were studied. Thirty-six patients (17.5%) failed the SBT, and were excluded of the final analysis. One hundred-and-seventy patients passed the SBT and were extubated. Twenty-three (13.5%) of these patients failed extubation and required re-instauration of MV within 24 h. The suspected etiology of extubation failure was mainly increased respiratory muscle load (52%), and cardiac failure (35%) (Additional file 1: Table S1). No baseline differences in demographic, hemodynamic, and respiratory variables were observed when comparing extubation success and extubation failure groups (Table 1). Hemodynamic and respiratory changes within the SBT were similar in both groups (Table 1).

Table 1.

Characteristics of the patients who succeed the spontaneous breathing trial (SBT)

	Extubation success (n = 147)		Extubation failure (n = 23)
Age (years)	66 ± 14		67 ± 12
Days on MV (n)	7 ± 5		8 ± 6
Pre-existent comorbidities (%)
Diabetes mellitus	33		35
Hypertension	57		48
Cardiac disease	23		22
COPD	16		30
Etiology of acute respiratory failure (%)
Septic shock	29		26
Heart failure	17		26
Respiratory	20		26
Trauma	6		0
Other	29		22

	Baseline	Minute 30	Baseline	Minute 30
HR (beats/min)	88 ± 16	91 ± 16†	83 ± 17	87 ± 18†
MAP (mmHg)	82 ± 13	85 ± 15†	79 ± 14	80 ± 12
RR (resp/min)	19 ± 4	23 ± 5†	18 ± 3	23 ± 4†
Vt (mL)	454 ± 96	430 ± 123†	438 ± 115	367 ± 132†
pH	7.46 ± 0.05	7.44 ± 0.06†	7.47 ± 0.04	7.44 ± 0.04†
pCO2 (mmHg)	37 ± 6	38 ± 6†	41 ± 9	42 ± 14 †
Hb (g/dL)	9.9 ± 1.8	9.9 ± 1.8	10.1 ± 2	10.3 ± 2.1
SaO2 (%)	96 ± 8	97 ± 3	97 ± 3	96 ± 3
ScvO2 (%)	66 ± 9	66 ± 8	62 ± 9	61 ± 5*
StO2 (%)	80 ± 6	80 ± 7	76 ± 11	77 ± 9
DeO2 (%/min)	− 13.1 ± 8.4	− 13.6 ± 10.7	− 12.7 ± 7	− 17.2 ± 10.3†
nirVO2 (U)	139 ± 80	159 ± 135†	129 ± 75	174 ± 97†
THI (U)	10.7 ± 2.9	11.3 ± 3.1†	10.0 ± 3.9	10.5 ± 4.0
ReO2 (%/s)	4.1 ± 1.6	4.2 ± 1.8†	3.3 ± 1.9*	3.7 ± 2.0
Hyperemia AUC (U)	12.2 ± 6.5	12.9 ± 5.7	7.1 ± 4.7**	8.4 ± 4.1**
DeO2 ratio		1.1 ± 0.3		1.5 ± 0.6**
nirVO2 ratio		1.1 ± 0.4		1.5 ± 0.5*

MV Mechanical ventilation, COPD Chronic obstructive pulmonary disease, HR heart rate, MAP mean arterial pressure, RR respiratory rate, Vt tidal volume, pCO₂ arterial partial pressure of carbon dioxide, Hb Hemoglobin, SaO₂ arterial oxygen saturation, ScvO₂ central venous oxygen saturation, StO₂ tissue oxygen saturation, DeO₂ StO₂ deoxygenation rate, nirVO₂ NIRS-derived local oxygen consumption, THI tissue hemoglobin index, ReO₂ StO₂ reoxygenation rate

* p < 0.05; and ** p < 0.01, as compared to success group at the same time point; ^†p < 0.05, as compared to baseline values within the group

StO₂ variables

Baseline ReO₂ and H_AUC values were significantly lower in the extubation failure group (Table 1). The weaning success group showed no significant changes in StO₂, DeO₂, and H_AUC after 30 min of SBT, while nirVO₂ and THI significantly increased. The extubation failure group showed a significant decrease in their DeO₂ slope, as well as an increase in nirVO₂ after 30 min of SBT, while no changes in StO₂, H_AUC and THI were observed. The DeO₂ ratio (represented as the ratio of DeO₂ at 30 min to baseline DeO₂) was significantly higher in the failure group (1.5 ± 0.6 vs. 1.1 ± 0.3 in the success group, p < 0.01). The nirVO₂ ratio was also higher in the failure group (1.5 ± 0.5 vs. 1.1 ± 0.4 in the success group, p < 0.05).

Extubation failure prediction

Univariate analysis showed that StO₂, ReO₂, and H_AUC at baseline, StO₂ and H_AUC after 30 min of the SBT, DeO₂ ratio, and nirVO₂ ratio were associated with extubation failure. In a multivariate analysis, only baseline StO₂, baseline H_AUC and DeO₂ ratio persisted significantly associated with extubation failure (Table 2).

Table 2.

Multivariate regression analysis

	B	ß	p	(95% CI)
Baseline StO2	− 0.075	0.93	0.03	0.87–0.99
Baseline hyperemic AUC	− 0.192	0.83	0.001	0.74–0.92
DeO2 ratio	2.849	17.3	< 0.001	4.1–72.8

The AUC for predicting extubation failure for baseline StO₂, baseline H_AUC, and DeO₂ ratio are displayed in Table 3. A logistic regression-derived StO₂ score, combining baseline StO₂, baseline H_AUC and DeO₂ ratio, proved an AUC of 0.84 (95% CI 0.74–0.93, p < 0.001) for prediction of extubation failure. An StO₂ score cut-off value of − 1.23 showed an LR + of 7 for predicting extubation failure (Additional file 2: Figure S1).

Table 3.

Prediction of extubation failure

	AUC	p	(95% CI)
StO2 at baseline	0.57	ns	0.43–0.72
DeO2 ratio	0.72	< 0.01	0.58–0.85
nirVO2 ratio	0.69	0.02	0.56–0.81
Hyperemia AUC0	0.73	0.01	0.58–0.88
Hyperemia AUC30	0.74	< 0.01	0.62–0.87
StO2 score	0.84	< 0.001	0.74–0.93
ScvO2 at min 30	0.72	0.04	0.58–0.85
% change in ScvO2	0.59	ns

DeO₂ratio quotient between StO₂-deoxygenation rate at the end of SBT and at baseline, nirVO₂ratio quotient between NIRS-derived local oxygen consumption at the end of SBT and at baseline, H_AUC area under the curve of the hyperemic response, StO₂ tissue oxygen saturation, ScvO₂ central venous oxygen saturation, % change in ScvO₂ refers to the % change in ScvO₂ at min 30 of the SBT as compared to baseline ScvO₂

Discussion

Our study demonstrates that alterations in StO₂-derived parameters were predictive of extubation failure after a clinically successful SBT.

To our knowledge, this is the first study showing that regional oxygenation parameters are associated with extubation outcome. The peripheral circulation has been previously studied in the setting of a cardiovascular stress test such as the SBT. Several studies showed that changes in gastric mucosal pH within the SBT were predictive of the clinical outcome of such SBT [12–15]. Similar results were obtained when assessing the peripheral circulation by means of NIRS, non-invasively monitoring oxygenation of the skeletal muscle within the SBT [16, 22, 23]. However, they were all small studies, and never explored the ability to predict the outcome of the overall weaning process. In this prospective study, we analyzed the utility of StO₂-derived parameters in the extubation process, after a clinically successful SBT. Our results add new evidence on the usefulness of regional non-invasive parameters as a complimentary tool in monitoring the cardiovascular performance of critically ill patients. Indeed, our data suggest that the inclusion of StO₂ monitoring in the weaning process might help prevent failed extubations, and therefore, the potential negative consequences on the outcome of critically ill patients.

Transitioning from positive pressure ventilation to spontaneous ventilation determines an increase in the work of breathing, and thus, an increase in the oxygen demand of the respiratory muscles. Such increase in the metabolic demand causes a sympathetic activation, in an attempt to optimize cardiac output delivery to the metabolically active tissues [24], and to increase vasomotor tone, redistributing blood flow away from the periphery toward the respiratory muscles [10, 25]. The ability of the cardiovascular system to meet this increased demand might be closely related to the ability of the patient to tolerate spontaneously breathing. Therefore, when the cardiovascular performance is limited, and/or the cost of breathing excessive, extubation failure will be more likely to occur. In these situations, the increase in sympathetic tone might be more accentuated, as the cardiovascular system continues to attempt to match cardiac output to an increasing metabolic demand. Indeed, clinical criteria for determining the success of the SBT are essential symptoms of excessive sympathetic activity (i.e., tachycardia, hypertension, agitation). A subclinical manifestation of the sympathetic activation would be the degree of peripheral vasoconstriction and/or the increase in the metabolic rate, and this is the basis for regional oxygenation measurements with NIRS.

Increased local oxygen extraction rate

Our data confirmed that relative increases in DeO₂ during a 30-min SBT are associated with extubation failure, independent of other respiratory and hemodynamic parameters. The observed increases in DeO₂ within the SBT might be explained by two different, but potentially concurrent, pathophysiological mechanisms: (1) local supply–demand dependency in low or inadequate blood flow states, such as blood flow diversion from the periphery; and (2) increase in local metabolic rate.

The increase in oxygen demand of the respiratory muscles during an SBT may lead to blood flow redistribution via activation of the sympathetic–adrenal system. When accentuated, this compensatory mechanism might cause a stealing effect from the periphery [10]. Accordingly, one would expect decreases in blood content of the sensed area [19, 26], along with relative increases in the DeO₂ rate (either due to the decreased Hb content or to the sympathetically driven increase in the metabolic rate). In our population, extubation failure was associated with significant increases in DeO₂, but no change in THI. Conversely, the success group showed no change in DeO₂, with significant increases in THI. Such observations suggest that cardiac output increased in those patients who succeeded the weaning process. In those patients who failed, since we did not measure stroke volume, the interpretation of the lack of changes in THI is more complex. In a model of simulated hypovolemia, Bartels et al. reported that THI measured on the thenar eminence detected slight decreases in stroke volume, but changes were minimal, as compared to measurements on the forearm [26]. Therefore, we cannot exclude some degree of stealing effect as results of a limited sensitivity of the technology. Finally, a balanced effect of increased cardiac output and peripheral vasoconstriction, resulting in no changes in THI, cannot be excluded.

NirVO₂, an estimation of local oxygen consumption [20, 21], increased in both groups during the SBT, but the magnitude of this increase was significantly higher in the extubation failure group. NirVO₂ differences might reflect dissimilar degrees in sympathetic activation in the setting of inadequate cardiovascular response. This hypothesis is supported by studies that showed significant increases in plasma catecholamines during the SBT, especially in patients who failed an SBT [27, 28]. Overall, our data suggest that the increase in DeO₂ in the extubation failure group might be mainly related to an increase in local oxygen consumption, although some degree of blood flow diversion cannot be ruled out.

Local hyperemic response after transient ischemia

We also observed that baseline endothelial performance, as measured by the StO₂ hyperemic response, was independently associated with extubation outcome. Our findings on the predictive value of the StO₂ hyperemic response are not surprising. Activation of the sympathetic nervous system is a major component of the neurohumoral response to the increased oxygen cost of breathing. Catecholamine release mediates vasoconstriction of peripheral vascular beds, and also, via ß-adrenoceptors, promotes vasodilation of the coronary arteries, and improves contractility. The functional impairment of the endothelium has been associated not only with poor peripheral response, but also with diminished ß-adrenoceptor sensitivity, limiting the cardiac response [29]. Therefore, endothelial dysfunction might be a potential marker of the ability of the patient to respond to the hemodynamic changes produced by the discontinuation of ventilatory support. According to our observations, we might hypothesize that vascular endothelial integrity, evaluated in peripheral skeletal muscle, might be relevant when facing a cardiovascular stress test such as transitioning from MV to spontaneously breathing.

Study limitations

Our study has relevant limitations. First, it was carried out in a single center. Albeit we expect that similar patients should behave similarly, weaning approaches may vary across centers affecting the predictive value of these StO₂-derived parameters. Thus, this study needs to be duplicated across other centers. Second, we did not determine the cause of weaning failure in patients who were considered to fail. We merely identified that they did fail. We can expect different behaviors of StO₂ parameters in patients who fail because of limited cardiovascular reserve from patients who fail because of upper airway obstruction and/or impaired secretions’ management. This issue must be taken into account in future studies. Finally, we studied a heterogeneous ICU population. Since the observed predictive value of StO₂ might vary across populations, further studies including selected homogeneous critically ill patients are required.

Conclusions

In a mixed ICU population, non-invasive StO₂-derived parameters at baseline, and within a 30-min SBT, were predictive of extubation outcome. Therefore, StO₂-derived parameters may be used as indicators of global VO₂/DO₂ balance when facing a cardiovascular stress test, such as liberation from mechanical ventilation.

Abbreviations

DeO₂

VOT-derived StO₂ deoxygenation rate

FiO₂

Fraction of inspired oxygen

H_AUC

StO₂ hyperemic response

HR

Heart rate

MAP

Mean arterial pressure

MV

Mechanical ventilation

NIRS

Near-infrared spectroscopy

nirVO₂

NIRS-derived thenar muscle oxygen consumption

P_aCO₂

Arterial carbon dioxide tension

PEEP

Positive end-expiratory pressure

ReO₂

VOT-derived StO₂ reoxygenation rate

RR

Respiratory rate

SBT

Spontaneous breathing trial

S_aO₂

Arterial oxygen saturation

S_cvO₂

Central venous oxygen saturation

S_pO₂

Pulse-oxymetry saturation

StO₂

Tissue oxygen saturation

THI

Tissue hemoglobin index

VO₂

Global oxygen consumption

VOT

Vascular occlusion test

Vt

Tidal volume

Authors’ contributions

JM, GG, AV, HG, MP, FB and AA were involved in the conception and the design of the study. JM, GG, CE, JM and CS collected the data. JM and JM analyzed the StO₂ records. JM performed the statistical analysis. JM, GG, AV, HG, MP, FB and AA discussed the results. All authors reviewed the manuscript and agreed with its final version. All authors read and approved the final manuscript.

Funding

The present study was supported by a Grant from the European Society of Intensive Care Medicine (ECCRN Clinical Research Award 2009), and a Grant from the Instituto de Salud Carlos III (FIS PS PI09/01000).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable demand.

Ethics approval and consent to participate

The local Ethics Committee (CEIC 2008/554) approved the study. Informed consent was obtained from the patient or their next of kin prior to the study initiation.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interest.

Supplementary information

Supplementary information accompanies this paper at 10.1186/s13613-020-00670-y.